Bhaskar Srivastava, MD, PhD

Dr Bhaskar Srivastava serves as the Chief Medical Officer at Triveni Bio, bringing extensive experience in clinical development and medical practice. Prior to joining Triveni Bio, Dr Srivastava was the Senior Vice President of Clinical Development at Nimbus Therapeutics, where he advanced novel therapies from discovery through clinical trials. Before his tenure at Nimbus, he held senior clinical development roles at Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on early-phase clinical programs in dermatology and rheumatology. Dr Srivastava is a board-certified dermatologist with five years of clinical practice experience and has served as an Assistant Professor of Dermatology at the Yale School of Medicine. He earned his MD and PhD in Immunology from the University of Pennsylvania.